Monoclonal Antibody Indications Flashcards
keliximab indication
Rheumatoid arthritis
abciximab (Reopro)
Antithrombotic for PCI
prevention of MI
alemtuzumab (Lemtrada)
Chronic lymphocytic leukemia
apolizumab indication
Chronic lymphocytic leukemia
Basiliximab indication
Prevention of acute renal allograft rejection
Clenoliximab indication
Rheumatoid arthritis
Daclizumab indication
Prevention of acute renal allograft rejection
Edrecolomab indication
Adjuvant therapy for cancer
after colorectal surgery
Efalizumab indication
Treatment of severe plaque psoriasis
Enlimomab indication
Burns; stroke; prevention of acute rejection in renal transplant
Epratuzumab indication
Non-Hodgkin’s lymphoma
Gemtuzumab indication
CD33
positive acute myelogenous leukemia
Infliximab indication
Rheumatoid arthritis; ankylosing spondylitis; Crohn’s disease
Inolimomab indication
Prevention of graft rejection
Keliximab indication
Rheumatoid arthritis
Muromonab indication
Prevention of acute renal allograft rejection
Natalizumab indication
Acute relapse in multiple sclerosis; Crohn’s disease
Ocrelizumab (Ocrevus) indication
Multiple Sclerosis
Odulimomab indication
Prevention of ischemic renal damage during kidney transplantation
Omalizumab indication
Prevention of allergic asthma and seasonal rhinitis
Palivizumab indication
Prevention of respiratory syncytial virus infection
Visilizumab indication
Treatment of glucocorticoid-refractory acute graft-versus-host disease
Rituximab, ofatumumab, obinutuzumab
indication
Hematologic malignancies
Trastuzumab, Amivantamab, Nivolumab, Pembrolizumab indication
Solid tumors
Adalimumab, Tocilizumab, Sarilumab indication
Autoimmune disorders
Evolucumab and Alirocumab indication
Hypercholesterolemia
Omalizumab indication
Asthma
Denosumab indication
Osteoporosis
Adalimumab, certolizumab pegol indication
Inflammatory bowel disease
Atoltivimab+maftivimab+odesivimab (Inmazeb), ansuvimab (Ebanga) indication
Ebola-specific therapies
Bezlotoxumab indication
Clostridioides difficile infection in adults
Idarucizumab (Praxbind) indication
Dabigatran reversal
Tixagevimab/cilgavimab (Evusheld) indication
COVID infection prevention in immunocompromised individuals who may not mount an adequate immune response to COVID-19 vaccination
Sotrovimab (Xeundy) indication
COVID. IV administration